Resource Type: Action Brief

With drug spending a top concern for plan sponsors and costs rising, employers continue to explore new strategies to better manage spending. New “shared savings” vendors attempt to appeal to employers […]

Recent advancements in the screening, diagnosis, and treatment of kidney disease have created an unprecedented opportunity for employers and other plan sponsors to intervene earlier to delay or prevent progression […]

Recent advancements in the screening, diagnosis, and treatment of kidney disease have created an unprecedented opportunity for employers and other plan sponsors to intervene earlier to delay or prevent progression […]

This two-part Action Brief series (see links, below) covers the basics of the fast-growing field of life-changing, life-saving — and costly — cell and gene therapies (CGTs). Learn to navigate […]

High blood pressure, also known as hypertension, is the most common health condition confronting 48% of US adults. Even though the US workforce is younger on average than the overall […]

As healthcare costs increase, employers and other plan sponsors continue to explore strategies to better manage pharmaceutical costs. Given that prescription drug spending accounts for 18% of all healthcare spending, […]

Stay current with National Alliance

Get updates on health policy, delivery and payment reform, and whole person health trends sent directly to your inbox.